Showing 2 of 2 recruiting trials for “glycogen-storage-disease-due-to-phosphoglucomutase-deficiency”
A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)
RecruitingNCT06636383 ↗
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →